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Other names: 12-LOX; 12S-type; 12(S)-lipoxygenase; 
EC 1.13.11.31; LOG12 
Location: 17p13.1 
Local order: According to NCBI Map Viewer, genes 
flanking ALOX15 in centromere to telomere direction 
on 17p13 are: GABARAP 17p13.1 GABA(A) receptor-
associated protein, ASGR2 asialoglycoprotein receptor 
2, ALOX12 17p13.1 arachidonate 12-lipoxygenase 
(Homo sapiens), ALOX12P2 17p13 arachidonate 12-
lipoxygenase pseudogene 2, TEKT1 tektin 1, FBXO39 
F-box protein 39. 
Note: Arachidonate 12-Lipoxygenase (12-LOX) is one 
of several LOX isoforms that has iron as a cofactor and 
oxygenates polyunsaturated fatty acids. This particular 
isoform was also the first documented LOX in the 
animal kingdom. 
DNA/RNA 
Note: With the exception of ALOX5, all human LOX  
genes, including ALOX12, are clustered on the short 
arm of chromosome 17 within a few megabases of each
other. ALOX15, which has 86% sequence homology to 
ALOX12, is in closest proximity (17p13.2). Since 
chromosome 17 is known for gene duplications, the 
multiple LOX genes on the same chromosome may be 
as a result of such duplications. 
Description 
According to Entrez-Gene, ALOX12 gene maps to 
NC_000017.9 and spans a region of 16.1 kilo bases. 
According to Spidey (mRNA to genomic sequence 
alignment tool), ALOX15 has 14 exons, the sizes being 
168, 202, 82, 123, 104, 161, 144, 210, 87, 170, 122, 
101, 171 and 490 bp. 
Transcription 
ALOX12 mRNA NM_000697 has 2335bp. 
Characterization of the 5' flanking region of the human 
ALOX12 in epidermoid carcinoma A431 cells 
indicated the presence of two Sp1 recognition motifs 
residing at -158 to -150 bp and -123 to -114 bp which 




Diagram of the ALOX12 gene. Exons are represented by grey boxes (in scale) untranscribed sequences in black, with exon numbers on 
the bottom. 
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The proposed mechanism of action is as follows: 
epidermal growth factor induces MAPK activation in 
cells, followed by the activation of JUN/AP1. The 
biosynthesis of c-Jun is thereby increased. Sp1 recruits 
HDAC1 together with c-Jun to the gene promoter. 
When Sp1 is deacetylated it interacts with acetylate 
histone 3, following which p300 is recruited to the gene 
promoter leading to the enhancement of the expression 
of 12(S)-lipoxygenase. 
Pseudogene 
According to Entrez Gene the arachidonate 12-
lipoxygenase pseudogene (ALOX12P2) (HGNC: 
13742) is located on 17p13.1. This is the 'epidermal 
type' 12-LOX (e-12LO) that was cloned using a murine 
e-LO12 probe. Humans express this functional 
pseudogene in the skin and hair follicles. 
Protein 
Note: 12S-lipoxygenases has three isoforms, named 
after their site of initial identification: platelet, 
leukocyte and epidermis. The leukocyte-type enzyme is 
expressed widely, while the platelet and epidermal 
enzymes are present in only a relatively limited number 
of cell types. Owing to the similarities in their genetic 
location, sequence and biological activities, leukocyte 
12-LOX and 15-LOX-1 are often referred to as 12/15 
lipoxygenase. 
Description 
12-LOX protein consists of 662 amino acids, with a 
molecular weight of 75536 Da and contains non heme 
iron as a cofactor. According to the NCBI conserved 
domain search, the presence of a 
polycystin/lipoxygenase/alpha-toxin (PLAT) domain in 
the 12-LOX protein allows it access and enables it to 
catalyze enzymatic lipid peroxidation in complex 
biological structures via direct dioxygenation of 
phospholipids and cholesterol esters of biomembranes 
and plasma lipoproteins. The same conserved domain 
in 15-LOX-1 also enables it to oxidize complex lipids. 
Although cytosolic, both types of enzymes need this
domain to access their sequestered membrane or 
micelle bound substrates. 
Expression 
The platelet type 12-LOX is expressed in the platelets 
and skin in humans. Based on structural and enzymatic 
properties, 15-LOX-1 is said to be a homolog of 
leukocyte type 12-LOX and are both expressed in mast 
cells, eosinophils, activated monocytes or dendritic 
cells, and bronchial epithelial cells. 
Localisation 
All 12-LOX isoforms have been localized to the 
cytoplasm. In addition, the platelet-type 12S-
lipoxygenase was found in both cytosol and 
microsomal fractions of epidermal cells of human skin. 
Function 
12-LOX is a member of the inflammatory leukotriene 
biosynthesis pathway where, in presence of molecular 
oxygen, it converts arachidonic acid to 12-
hydroxyeicosatetraenoic acid (12-HETE). The 
leukocyte type 12-LOX can, in addition, effectively 
oxygenate linoleic acid and phospholipids. This 
isoform can also generate significant amounts of the 
15-LOX product in addition to 12-HETE. 
Homology 
C. familiaris: LOC479476 similar to arachidonate 12-
lipoxygenase, P. troglodytes: ALOX12, R. norvegicus: 
Alox12 (predicted), M. musculus: Alox12 arachidonate 
12-lipoxygenase (12/15LOX), D. rerio: wufb72a11. 
Implicated in 
Inflammation and cancer 
Note: End product of arachidonic acid metabolism by 
the platelet-type 12-LOX 12(S)-Hydroxy 
eicosatetraenoic acid (12(S)-HETE) is shown to induce 
invasion, motility, and angiogenesis and protect tumo r 
cells from apoptosis. Great many biological activities 
of 12(S)-HETE appear to be partly mediated by the 
activation of NF-kappaB. NF-kappaB is a family of 
five DNA binding proteins that regulate the expression 
of a variety of genes involved in host immune 
responses and inflammation. A direct relationship 
between platelet-type 12-LOX overexpression and NF-
kappaB activation is reported in prostate cancer cells. 
Polymorphisms associated with 
diseases 
Note: Aberrant arachidonic acid metabolism by 12-
lipoxygenase (12-LOX) is implicated in carcinogenesis. 
Genetic polymorphisms 12-LOX is therefore thought to 
influence its function and/or expression and may 
modify the risk for colorectal adenoma. One of the 
single nucleotide polymorphisms (SNPs) reported in 
the 12-LOX gene located in exon 6 resulting in an Arg
to Gln substitution at amino acid 261 of 12-LOX is in a 
highly conserved region of the lipoxygenase domain. 
Data from a community-based, case-control study of 
incident, sporadic colorectal adenoma that included 162 
cases and 211 controls have shown an inverse 
association between the Arg261Gln polymorphism in 
12-LOX and colorectal adenoma (OR, 0.63; 95% CI, 
0.40-1.00). A significant interaction also is observed 
between the 12-LOX polymorphism (Arg261Gln) and 
the use of nonsteroidal anti-inflammatory drugs. 
Another study argues that Gln261Arg in ALOX12 does 
not appear to be associated with colon cancer risk. 
Studies have shown higher urinary excretion of the 
arachidonic acid-derived metabolite 12-
(S)hydroxyeicosatetraenoic acid (12(S)-HETE) in 
essential hypertension. For analysis of the associati n 
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of polymorphisms in ALOX12 with hypertension and 
urinary levels of 12(S)-HETE, a study with 200 
patients with essential hypertension and 166 matched 
controls is performed and as a result, the distribution of 
genotypes of the R261Q (Arg to Gln) polymorphism is 
found to be significantly different between patients and 
controls. These results indicate that a nonsynonymous 
polymorphism in ALOX12 is associated to essential 
hypertension and to urinary levels of 12(S)-HETE. 
Peak BMD is a major determinant of osteoporosis 
which is a complex disease with both genetic and 
environmental risk factors. In a population - and family 
- based association study of ALOX15 and ALOX12, 
SNPs distributed across the two genes are genotyped. 
Moderate evidence of association is found between 
spine BMD and six SNPs in the ALOX12 gene in both 
men and women. These data conclude that 
polymorphisms in the ALOX12 gene may contribute to 
normal variation in spine BMD. 
Alzheimer's disease 
Note: Alzheimer's disease (AD) is a chronic 
neurodegenerative disorder that impairs cognition and
behavior. Although the initiating molecular events are 
not known, increasing evidence suggests that 12/15-
LOX is a major source of oxidative stress which could 
play a functional role in pathogenesis. Quantitative 
Western blot analysis confirmed by 
immunohistochemical studies demonstrate that in 
affected frontal and temporal regions of AD brains, the 
amount of 12/15-LOX is higher compared to controls. 
Also metabolic products of 12/15-LOX are markedly 
elevated in AD brains compared to controls. 
Bladder cancer 
Note: 12-LOX expression is shown to be induced in 
bladder cancer tissues by an immunohistochemistry 
analysis. Also lipoxygenase inhibitors cause marked 
inhibition of bladder cancer cells in a concentration and 
time dependent manner. Cells treated with 
lipoxygenase inhibitors show chromatin condensation, 
cellular shrinkage, small membrane bound bodies 
(apoptotic bodies) and cytoplasmic condensation. 
Testicular cancer 
Note: 12-LOX is only slightly expressed in normal 
testis tissues, however, 12-LOX expression is found to 
be significant in testicular cancer tissues by 
immunohistochemistry studies. Specific LOX 
inhibitors have also been shown to inhibit the growth of 
testicular cancer in cell lines. 
Prostate cancer 
Note: Research focusing on mechanisms of action of 
12-lipoxygenase in prostate cancer cells revealed that 
overexpression of 12-lipoxygenase in PC-3 cells results 
in a 3-fold increase in VEGF protein level when 
compared with vector control cells and there is an 
increase in PI3-kinase activity in 12-LOX-transfected 
PC-3 cells. 
The expression of 12-LOX is detected to be low in 
benign prostatic hyperplasia and normal prostate 
tissues, whereas marked expression of 12-lipoxygenase 
is detected in prostatic intraepithelial neoplasia and 
prostate cancer tissues. The LOX inhibitors cause 
marked cellular death through apoptosis in prostate 
cancer cells in a concentration and time-dependent 
manner. 
Another effect of 12-LOX in prostate cancer cells is 
that increase in 12-LOX expression enhances the 
metastatic potential of human prostate cancer cells. 12-
LOX transfected PC-3 cells show a significant change 
in cell adhesiveness, spreading, motility, and 
invasiveness. 
Breast cancer 
Note: Total cellular RNA extraction from 64 frozen 
tissue samples of breast carcinoma and their 
corresponding normal adjacent tissues is performed for 
expression analysis of cyclooxygenase-2 and 12-
lipooxygenase using RT-PCR. 62.5% of carcinoma 
samples showed over-expression of 12-lipooxygenase 
as compared to normal breast tissues. Results also 
reveal that and 12-lipooxygenase mRNA expressions 
are associated with TNM staging in human breast 
cancer. 
A second study indicates that levels of 12- 
lipoxygenases together with 5-lipoxygenase are also 
particularly high in tumours from patients who died of 
breast cancer. Therefore raised level of 12-
lipoxygenase might have prognostic value in patients 
with breast cancer. 
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